Social Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Social Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Social Anxiety Disorder Study Of Paroxetine [Phase 3]
A Phase 3 trial of paroxetine for social anxiety disorder (social phobia) has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Long-term Study Of Paroxetine in Women and Men [Phase 3]
Completed Phase 3 long-term study evaluating paroxetine in men and women with social anxiety disorder (social phobia) sponsored by GlaxoSmit…
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders [Phase 2, Phase 3]
This document reports the results of cognitive-behavioral therapy for anxiety disorders in children with autism spectrum disorders across Ph…
-
FDA approval · 2013-02-01FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
FDA approved a supplemental application for ZOLOFT (sertraline hydrochloride) submitted by ROERIG.
-
FDA label_change · 2013-02-01FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA supplemental approval for sertraline hydrochloride from Mylan to update labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-01-29FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for sertraline hydrochloride from Rising Pharma Holdings, Inc., indicating approval of changes to th…
-
FDA approval · 2012-12-21FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for sertraline hydrochloride by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2012-12-18FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for Paxil (paroxetine hydrochloride) submitted by Apotex Corp.
-
FDA approval · 2012-12-18FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2012-12-11FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
The FDA approved a supplemental application for venlafaxine hydrochloride from Vertical Pharmaceuticals, LLC, expanding the drug’s approved …
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Glucocorticoid Treatment for Social Phobia [Phase 2]
A Phase 2 trial evaluating glucocorticoid treatment for social anxiety disorder has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Social Phobia Intervention Study of Mannheim [NA]
A completed clinical trial in Mannheim studying an intervention for social anxiety disorder with results posted in 2012.
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approval of a supplemental application for venlafaxine from BluePoint Laboratories (ANDA).
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for venlafaxine hydrochloride from Aurobindo Pharma Limited, resulting in approval of a generic venl…
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride submitted by Teva Pharmaceuticals USA, Inc., resulting in changes to t…
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for venlafaxine hydrochloride from Aurobindo Pharma Limited.
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for venlafaxine hydrochloride submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride from Zydus Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS research · 2012-09-19Clinical Trial Update: Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children [NA]
This clinical trial evaluates adding attentional bias modification treatment to either cognitive behavioral group therapy or a psychoeducati…
-
FDA approval · 2012-07-31FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for venlafaxine by Alembic Pharmaceuticals Inc. to support a generic version of the antidepressant. …
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: A Systems Level Intervention for Unemployed Persons With Social Anxiety Disorder [Phase 2, Phase 3]
This entry reports the completion of Phase 2 and Phase 3 trials of a systems-level intervention for unemployed persons with social anxiety d…
-
FDA approval · 2012-07-31FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for a generic paroxetine hydrochloride product submitted by NorthStar Rx LLC.
-
FDA approval · 2012-07-31FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for paroxetine hydrochloride from Zydus Lifesciences Limited, authorizing its marketing as a gen…
-
FDA approval · 2012-06-26FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical’s supplemental application for venlafaxine hydrochloride, a generic product. The approval relates to the sta…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome [Phase 3]
Phase 3 clinical trial update reports long-term outcome predictions for duloxetine in social anxiety disorder. The study has completed and r…